Nurses Improve the Care Experience for Bone Marrow Transplant Recipients
Patients who receive bone marrow transplantations require vigilance for complications such as graft versus host disease, opportunistic infections, and febrile neutropenia. During a presentation for the inaugural ONS Bridge™ virtual conference, Barbara E. Wenger, DNP, APRN, AOCNS®, CRNI, of UCHealth Metro, and Stephanie Armstrong, DNP, AGNP, NP-C, of Froedtert Hospital Clinical Cancer Center, described interventions to improve care quality in the BMT population.
- Read more about Nurses Improve the Care Experience for Bone Marrow Transplant Recipients
- Add new comment
What Oncology Nurses Should Know About Medical Physicists in Radiation Oncology
As many as 50% of patients with cancer receive treatment with radiation therapy with the goal of cure or reducing pain and other symptoms. During a presentation at the inaugural ONS Bridge™ virtual conference, Sotiri Stathakis, PhD, DABR, offered nurses insights into the field from the perspective of a medical physicist.
- Read more about What Oncology Nurses Should Know About Medical Physicists in Radiation Oncology
- Add new comment
Oncology Nurses Have a Responsibility to Manage the Financial Toxicities of Cancer
Cancer is one of the most expensive medical conditions to treat, and patients are expected to pay more and more out of pocket. Costs often lead to financial toxicity, defined as “distress or hardship arising from the financial burden of cancer treatment,” according to Darcy Burbage, DNP, RN, AOCN®, CBCN®, who discussed the topic in a session for the inaugural ONS Bridge™ virtual conference.
- Read more about Oncology Nurses Have a Responsibility to Manage the Financial Toxicities of Cancer
- Add new comment
Rebecca Collins
ONS Guidelines Give Clinicians Evidence-Based Recommendations for Cancer Treatment-Related Side Effects
Resources that can be used by nurses and other oncology healthcare professionals, patients, and policymakers to improve the care of patients with cancer, were recently launched by the Oncology Nursing Society (ONS) in its first set of five systematically reviewed clinical practice ONS Guidelines™ for managing cancer treatment-related side effects.
- Read more about ONS Guidelines Give Clinicians Evidence-Based Recommendations for Cancer Treatment-Related Side Effects
- Add new comment
ONS Guidelines™ Offer Framework for Managing Treatment-Related Hot Flashes
Because of treatment effects on hormones, women with breast cancer and men with prostate cancer have an increased risk of frequent and severe hot flashes after treatment. As many as 80% of patients across both genders experience the symptom, which can have an impact on sleep, mood, energy, and sexual function.
- Read more about ONS Guidelines™ Offer Framework for Managing Treatment-Related Hot Flashes
- Add new comment
FDA Approves Pralsetinib for Lung Cancer With RET Gene Fusions
On September 4, 2020, the U.S. Food and Drug Administration (FDA) granted accelerated approval to pralsetinib (Gavreto™) for adult patients with metastatic, RET fusion-positive non-small cell lung cancer (NSCLC) as detected by an FDA approved test.
MicroRNA May Be Key Factor in High-Grade Ovarian Cancer Development
The miR-181a microRNA may turn off two genes and lead to the development of high-grade serous ovarian cancer, researchers reported in Nature Communications. The finding is significant because not much is known about how ovarian cancer develops and it’s difficult to detect in its earlier stages.
FDA Rejects Atezolizumab in Combination With Paclitaxel as Treatment for Breast Cancer
On September 8, 2020, the U.S. Food and Drug Administration (FDA) announced it did not approve atezolizumab (Tecentriq®) in combination with paclitaxel for treatment of breast cancer after a clinical trial studying the use of atezolizumab and paclitaxel in patients with previously untreated inoperable locally advanced or metastatic triple negative breast cancer (mTNBC) showed the drug combination did not work to treat the disease.
- Read more about FDA Rejects Atezolizumab in Combination With Paclitaxel as Treatment for Breast Cancer
- Add new comment
Advanced Practice Providers Serve a New Role in Radiation Oncology
No matter the subspecialty, advanced practice RNs have a significant role in patient treatment and care, but little data exist about their role in radiation oncology. During a presentation at the inaugural ONS Bridge virtual conference, Lorraine Drapek, DNP, FNP-BC, AOCNP®, of Massachusetts General Hospital, and Katie Bukolt, MSN, APRN, NP-C, AOCNP®, of Baylor Charles A. Sammons Cancer Center, discussed the nuances of advanced practice in radiation therapy settings.